跳至主要内容
临床试验/NCT07328880
NCT07328880招募中不适用

Comparative Study Between Using a 4-L Split-dose Polyethylene Glycol and Bisacodyl + Docusate Sodium Regimen Versus a 2-L Split-dose Polyethylene Glycol Plus Oral Simethicone Regimen Versus Conventional Method for Bowel Preparation Before Colonoscopy

Tanta University1 个研究点 分布在 1 个国家目标入组 450 人开始时间: 2025年4月1日最近更新:
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
450
试验地点
1
主要终点
Performing a complete and successful full colonoscopy.

研究概览

简要总结

The goal of this randomized controlled trial is to compare the safety, compliance, and efficacy of different bowel preparation methods prior to colonoscopy. Researchers will compare 4-L split-dose polyethylene glycol and the bisacodyl + docusate sodium regimen versus 2-L split-dose polyethylene glycol plus oral simethicone regimen versus the conventional method for bowel preparation before colonoscopy. Participants will undergo history-taking, clinical examination, laboratory investigations, and colonoscopy. Patients will be randomly assigned to receive 4-L split-dose polyethylene glycol and bisacodyl + docusate sodium, a 2-L split-dose polyethylene glycol regimen plus oral simethicone, or 2-L split-dose polyethylene glycol alone as a control. Colonoscopy will be done 24 hrs after the start of medication. Researchers will assess the quality of the bowel preparation using the Aronchick bowel preparation scale. Researchers will also assess the number of adverse events and ask the patients about the ease of bowel preparation administration, tolerability of preparation regimen, and willingness to take the same agent again for a repeat colonoscopy in the future.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients undergoing colonoscopy as a day-care procedure for various indications (lower GI bleeding, colorectal cancer screening, altered bowel habits, etc.)
  • Patients of either sex aged >18 years and <70 years.
  • Patients willing to give written informed consent.

排除标准

  • Presence of Renal failure, cirrhosis, ascites, CCF, bleeding disorders, seizure disorder, gastrointestinal obstruction, or perforation.
  • History of serious adverse events to other electrolyte-based colonic lavages.
  • Female patients who are pregnant or lactating or considering pregnancy.

研究组 & 干预措施

4-L split-dose polyethylene glycol and Bisacodyl + docusate sodium.

Experimental

150 patients will be randomized to receive PEG and were instructed to mix four sachets of PEG (Moviprep) in 4 liters of water and drink it over a period of 8 hours starting at 09:00 a.m. and Biscodyl 10 mg + Docusate sodium 100 mg (Minalax) 8 tablets.

干预措施: 4-L split-dose polyethylene glycol and Bisacodyl + Docusate sodium. (Drug)

2-L split-dose polyethylene glycol plus oral simethicone regimen .

Active Comparator

150 patients will be randomized to receive PEG with simethicone and instructed to mix two sachets of PEG (Moviprep) in 2 liters of water and drink it over a period of 4 hours starting at 09:00 a.m. with simethicone (Flatidyl) 4 tablets.

干预措施: 2-L split-dose polyethylene glycol plus Oral Simethicone regimen . (Drug)

2-L split-dose polyethylene glycol regimen (control).

Active Comparator

150 patients will be randomized to receive PEG with simethicone and instructed to mix two sachet of PEG (moviprep) in 2 liters of water and drink it over a period of 4 hours starting at 09:00 a.m.

干预措施: 2-L split-dose polyethylene glycol regimen (Drug)

结局指标

主要结局

Performing a complete and successful full colonoscopy.

时间窗: through study completion, an average of 1 year

Bowel preparation administration, whether completed or not, and the reason for it will be recorded. Assessment of the quality of the bowel preparation using the Aronchick bowel preparation scale.

次要结局

  • Bowel preparation side effects(through study completion, an average of 1 year)
  • Ease of bowel preparation administration(through study completion, an average of 1 year)
  • Tolerability assessment(through study completion, an average of 1 year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Rania Mamdouh Elkafoury

Lecturer of Tropical Medicine

Tanta University

研究点 (1)

Loading locations...

相似试验

4-L Split-dose Polyethylene Glycol and Bisacodyl and... | 临床试验